Peregrine Pharmaceuticals reported $3.52M in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
AstraZeneca AZN:LN 1954M 415M
Bristol Myers Squibb BMY:US $ 5289M 67M
Celldex Therapeutics CLDX:US $ -20.68M 7.31M
Chemocentryx CCXI:US $ -22.31M 16.9M
Dicerna Pharmaceuticals DRNA:US $ -16.26M 24.01M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Immunogen IMGN:US $ -37.34M 6.6M
Intrexon XON:US $ -29.88M 9.76M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Kindred Biosciences KIN:US $ -9.13M 0.61M
Macrogenics MGNX:US $ -52.89M 12.95M
Mannkind MNKD:US $ -4.43M 31.1M
Minerva Neurosciences NERV:US $ -9.2M 1.38M
Newlink Genetics NLNK:US $ -7.49M 1.18M
Novartis NOVN:VX SF 4544M 120M
Novavax NVAX:US $ -316.39M 32.38M
Peregrine Pharmaceuticals PPHM:US $ 3.52M 2.78M
Repligen RGEN:US $ 55.91M 0.3M
Xencor XNCR:US $ -40.19M 92.44M